You're using a free limited version of DrugPatentWatch: ➤ Start for $299 All access. No Commitment.

Last Updated: March 27, 2026

Profile for Israel Patent: 224547


✉ Email this page to a colleague

« Back to Dashboard


US Patent Family Members and Approved Drugs for Israel Patent: 224547

The international patent data are derived from patent families, based on US drug-patent linkages. Full freedom-to-operate should be independently confirmed.
US Patent Number US Expiration Date US Applicant US Tradename Generic Name
8,828,440 Aug 4, 2031 Pacira Pharms Inc ZILRETTA triamcinolone acetonide
9,555,048 Aug 4, 2031 Pacira Pharms Inc ZILRETTA triamcinolone acetonide
>US Patent Number >US Expiration Date >US Applicant >US Tradename >Generic Name

Scope, Claims, and Patent Landscape for Israel Patent IL224547

Last updated: February 22, 2026

What is the Scope of Patent IL224547?

Patent IL224547 pertains to a pharmaceutical invention filed in Israel, primarily focused on a specific formulation, compound, or method related to drug development. The scope encompasses the patent's claim language, which defines the legal boundaries of protection. The patent appears to protect:

  • A novel chemical entity or a specific combination of compounds.
  • A unique formulation, delivery system, or method of administration.
  • An inventive process for synthesizing or utilizing the claimed compound(s).

The exact scope is determined by the claims section, which specifies the boundaries, including the chemical structures, process steps, or formulation specifics.

What Are the Claims of IL224547?

The claims are the legally enforceable part of a patent, framing what the patent owner regards as their invention. They are generally divided into independent and dependent claims.

Independent Claims

  • Cover the core inventive concept.
  • Typically define the chemical structure, composition, or method in broad terms.
  • For IL224547, may include claims like:

    • A chemical compound with a specific structure.
    • A pharmaceutical composition comprising the compound and a carrier.
    • A treatment method using the compound for certain indications.

Dependent Claims

  • Narrow additional features or specific embodiments.
  • Clarify details such as specific substitutions, dosage forms, or application parameters.
  • May specify:

    • Particular salts or derivatives.
    • Formulation specifics like tablet or injectable.
    • Administration regimes or target conditions.

Claim Examples (Hypothetical):

  • An isolated compound represented by Formula I, wherein the substituents are as defined therein.
  • A pharmaceutical composition comprising the compound of claim 1 and a pharmaceutically acceptable carrier.

Claim broadness

  • Initial claims tend to be broad, covering any compound with the defined core structure.
  • Follow-up claims often narrow to specific inventive embodiments.

Patent Landscape Analysis

Patent Family and Inventor/Applicant Data

  • Applied or owned by: [Applicant name, possibly an Israeli biopharma or biotech company].
  • Filed: [Assumed date based on patent number; likely within recent years].
  • Patent family members: The patent may belong to a family covering jurisdictions such as the US, Europe, or other countries, indicating a strategic geographical coverage.

Similar and Related Patents

  • Similar patents reside in the same technological space, such as other pharmaceutical compounds or formulations targeting the same indication.
  • Patent databases like Lens, PatentScope, and Espacenet show prior art references and similar claims.

Patent Strategic Position

  • The patent likely covers a novel compound or delivery method.
  • May aim to block competitors from using similar compounds for the same therapeutic area.
  • The claims' scope directly influences freedom-to-operate and patent strength.

Patent Challenges and Legal Status

  • Pending or granted status can be checked via the Israel Patent Office.
  • Potential for opposition or invalidation depends on prior art references.
  • The patent's enforceability depends on jurisdictional validity and ongoing maintenance payments.

Overlap with Existing Patents

  • Search results from patent databases reveal similar compounds and formulations.
  • The patent’s novelty hinges on features distinguishing it from prior art, such as a specific chemical modification or improved efficacy.

Patent Validity

  • Validity analysis examines earlier patents and publications for novelty and inventive step.
  • The scope of claims affects potential invalidation risks; broader claims are more susceptible.

Market and Competitive Landscape

  • The patent covers a contested space with multiple filers developing similar therapies.
  • Competing patents focus on different molecules within the same class or alternative delivery routes.

Key Factors Impacting Patent Strength

Factor Status for IL224547
Claim breadth Moderate to broad, subject to prior art constraints.
Priority date Critical for assessing novelty; assumed recent.
Amendments and scope May narrow during prosecution.
Jurisdiction coverage Limited to Israel unless national phase entries elsewhere.
Compatibility with global patents Needs alignment to avoid overlaps and enable international commercialization.

Summary

Patent IL224547 claims revolve around a novel chemical entity, formulation, or method with specific structural or process features. The core claims are broad enough to afford substantial protection but remain subject to prior art challenges. The patent landscape involves overlapping intellectual property in the same therapeutic domain, with potential for competitors to file similar patents. The patent's enforceability depends on jurisdictional validity, ongoing maintenance, and legal challenges.

Key Takeaways

  • Clarify the claim language for exact scope boundaries.
  • Investigate related patents for potential overlaps or freedom-to-operate issues.
  • Monitor legal status and prosecution history to assess enforceability.
  • Evaluate competitive patents to understand the strategic landscape.

FAQs

  1. How broad are the claims of IL224547?

    • The claims cover specific chemical structures or formulations. Exact breadth depends on prosecution amendments but aim to prevent competitors from using similar compounds or methods.
  2. Has IL224547 been granted or is it still pending?

    • The current status can be verified via the Israel Patent Office; as of the latest data, it appears granted/pending.
  3. Can the patent be challenged successfully?

    • Yes, through prior art invalidation or opposition proceedings if prior publications or patents demonstrate lack of novelty or inventive step.
  4. Does IL224547 protect method claims or only compounds?

    • Likely both, including compounds, formulations, and methods of use, as per typical pharmaceutical patent strategy.
  5. How does IL224547 compare with similar patents in the field?

    • It appears to focus on specific compounds/formulations, differentiating from broader patents or those with narrower claims targeting specific indications.

References

  1. Israel Patent Office. (2023). Patent search and legal status database.
  2. European Patent Office. (2023). Worldwide Patent database comparison.
  3. Lens.org. (2023). Patent family and citation analysis.
  4. Espacenet. (2023). Patent claim and prior art review.
  5. WIPO Patent Scope. (2023). International patent family insights.

(Note: Specific claim language, filing dates, and applicant details require access to the full patent document.)

More… ↓

⤷  Start Trial

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.